Press releases
- Press releases
- Browse
Press releases
APR Applied Pharma Research will soon present results of the phase III efficacy trials with ketoprofen patch in the treatment of tendinites and ankle sprains at the annual meetings of the American College of Rheumatology and of the French Society of More
ProEthic Laboratories, LLC and Applied Pharma Research have signed a licensing agreement for a once-daily transdermal version of ketoprofen, a member of the NSAID class of drugs that also includes the popular Celebrex and Vioxx brands. More
The Swiss based Drug Delivery Company APR Applied Pharma Research has recently published very successful results on tissue absorption and distribution of ketoprofen TDS patch. More
A polymorphism in the PDCD1 involved in susceptibility for SLE More
EUROPEAN MEDICINES EVALUATION AGENCY (EMEA) STATES THAT NIMESULIDE IS SAFE AND EFFECTIVE More
EULAR Congress, Lisbon 18-21 June 2003: Helsinn Satellite Symposium - The Management of Pain and Inflammation: What is the Role of NSAIDs? More
OXAPROZIN: AN INCREASING PERFORMANCE THROUGH NEW MARKET LAUNCHES More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 40 pages - $500
Dec 2010 - 84 pages - $500
Mar 2011 - 34 pages - $1,000
Nov 2011 - 7 pages - $3,835
Mar 2011 - 16 pages - $250
Jun 2006 - 378 pages - $2,495
Apr 2009 - 450 pages - $3,490
Nov 2007 - 173 pages - $1,860
Oct 2010 - 169 pages - $3,500
Oct 2011 - 134 pages - $500
Your selection
Browse By
- Industry sector
- Academic/Research
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Non-profit org./Government
- Pharmaceutical
- Research tools
- Service
- Therapeutic target
- Arthritis (non-specific)
- Bone fractures
- Bone repair/regeneration
- Osteoarthritis
- Osteopetrosis
- Osteoporosis
- Paget's disease
- Rheumatic disorders (other)
- Rheumatoid arthritis
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us